The speaker of the HERA lecture said that er,pr+ relapses later than er,pr-so I think that it makes sense that the more nodes involved, the more likely a relapse with er, pr+ because multimple node involvement signifies the disease has been there for some time.

SABCS link
 

Robin posted a link 7or 8 posts up in this thread. Just click on it.

Sassy
________
GLASS BONG

distant sites
 

The problem seems that assessing the status, either HER2, E or P, seems to by the one treatment limiting factor. When asked at SABCS, Dr. Sleaman stated that when ever a biopsy of distant metastatic sites is done, either by fine needle aspiration or core needle biopsie (the most common) there is always the posibility of spread, however remote. I must wonder if the Bayer test, or a variation of it, for serum HER2 cells might be a future way of assessing the change in HER2 status. I may e-mail Bayer for feed-back, as a possible future direct. I think that this is a HUGH issue given the fact that a very large percentage of stage 4'ers may be under-treated.
Al

HI Robin,

Where I can find the 2005 SABC live webcast with Dr. D. Slamon, discussing the trail results of BCIRG , Do you have a link because I can't find it on the site--or maybe I'm going to the wrong site.

Thanks for the help,


VIVIANE

I've tried the SABC site repeatedly the last two days and it is down! Sorry.

When its up try

http://www.sabcs.org/